For our first video in this month of gratitude, Linnea Olson stepped in front of the camera. Linnea is one of many of our amazing GRACE community who works hard as the best kind of patient advocate. Helping others to learn about lung cancer helps us all.

In this twelfth video from the Targeted Therapy in Lung Cancer Live Patient Forum Webcast series, GRACE presents the afternoon breakout sessions. The fourth video from these sessions is Dealing with Down Days, presented by Jeanice Hansen, MSW, LCSW, OSW-C.

November is month of gratitude in the U.S. It is also Lung Cancer Awareness Month (LCAM). Cancer patients have a unique perspective on gratitude, so it is only fitting that we combine them for our second LCAM Gratitude Campaign. Each day this month...

In this eleventh video from the Targeted Therapies in Lung Cancer Patient Forum, the third from the afternoon breakout survivorship sessions, GRACE presents Chemo Brain, with Denise Damek, MD.

In this tenth video, the second from the afternoon breakout survivorship sessions, GRACE presents the Cancer Kitchen, with Lisa Wingrove, RD, CSO. Lisa is joined in this video by her lovely kitchen helper, Chris Draft.

In this ninth video from the webcast series, GRACE presents the breakout survivorship session - Bankruptcy and Workplace Discrimination with Patricia McMahon and Carlos Colon, AFC.

In this eighth video from the webcast series, GRACE presents the lunchtime keynote discussion: The Evolving Landscape of Molecular Testing in Lung Cancer: Who, How and When? featuring Dr. Dara Eisner.

In this seventh video from the Targeted Therapy in Lung Cancer Live Patient Forum Webcast series, GRACE presents the lunchtime Lung Cancer Champion Award, presented to Chris Draft by GRACE founder, H. Jack West.

Our sixth video is from the forum breakout session for EGFR patients and caregivers, featuring co-chairs Dr. Greg Riely and Dr. Jack West, and patient moderator Bob Fuerst.

Amidst all of the glowing reports about immunotherapy for lung and many other cancers, it would be understandable for patients and physicians to be tempted to rush toward prioritizing immunotherapy as the first treatment strategy to pursue. In fact ...